Clinical characteristics and etiology analysis of nonvariceal upper gastrointestinal bleeding in the treatment of different antithrombotic drugs

CHEN Hongbo; WANG Yuanyuan; LI Jing; CAO Yabing; LI Zhengchuan

doi:10.7619/jcmp.20223326

Journal of Clinical Medicine in Practice > 2023 > 27(3): 81-85. > DOI: 10.7619/jcmp.20223326

CHEN Hongbo, WANG Yuanyuan, LI Jing, CAO Yabing, LI Zhengchuan. Clinical characteristics and etiology analysis of nonvariceal upper gastrointestinal bleeding in the treatment of different antithrombotic drugs[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 81-85. DOI: 10.7619/jcmp.20223326

Citation:

PDF (655 KB)

Clinical characteristics and etiology analysis of nonvariceal upper gastrointestinal bleeding in the treatment of different antithrombotic drugs

1.
Cardiovascular Department, Xingtai Third Hospital of Hebei Province, Xingtai, Hebei, 054000
2.
Digestive Geriatrics Department, Xingtai Third Hospital of Hebei Province, Xingtai, Hebei, 054000
3.
Endocrinology Hematology Department, Xingtai Third Hospital of Hebei Province, Xingtai, Hebei, 054000

More Information

Received Date: November 07, 2022
Available Online: March 01, 2023

Graphical Abstract

Abstract

Abstract

Objective
To explore clinical characteristics and etiology of complicating non-variceal upper gastrointestinal bleeding (NVUGIB) patients with different oral antithrombotic drug.
Methods
Clinical data of 535 patients complicated with NVUGIB during oral administration of antithrombotic drugs were retrospectively analyzed and they were divided into antiplatelet group and anticoagulant group according to different types of antithrombotic drugs. General data, clinical characteristics and etiology of patients in the two groups were compared and analyzed.
Results
The proportion of male in the antiplatelet group was higher than that in the anticoagulant group (P=0.012). The proportions of patients complicating coronary heart disease, hypertension and diabetes in the antiplatelet group were higher than that in anticoagulation group, and the proportion of patients complicating atrial fibrillation, heart valve disease, pulmonary embolism or deep vein thrombosis was lower than that in the anticoagulant group (P < 0.05). The proportion of patients with NVUGIB in the antiplatelet group within 1 month after taking the medicine was higher than that in the anticoagulant group (P < 0.05). The proportion of patients with chest tightness and chest pain in the antiplatelet group was higher than that in the anticoagulant group, while the proportion of patients with abdominal pain was lower than that in the anticoagulant group (P < 0.05). The proportion of patients using acid suppressant and Hp infection rate in the antiplatelet group were higher than those in the anticoagulant group (P < 0.05). The common causes of NVUGIB in the two groups were peptic ulcer, acute gastric mucosal lesion and malignant tumor.
Conclusion
NVUGIB with oral antithrombotic therapy usually occur in elderly men. The top three causes are peptic ulcer, acute gastric mucosal lesion and malignant tumor. There are some differences in underlying diseases, oral duration of antithrombotic drugs, symptoms and etiology in antiplatelet and anticoagulant patients with NVUGIB. Thus, clinicians need to pay attention to their difference.
- antiplatelet,
- anticoagulation,
- non-variceal upper gastrointestinal bleeding,
- clinical characteristics,
- etiology

FullText(HTML)

References (17)

References

[1]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志, 2020, 35(9): 833-854. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202009001.htm
[2]	HAMON M, LEMESLE G, TRICOT O, et al. Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease[J]. J Am Coll Cardiol, 2014, 64(14): 1430-1436. doi: 10.1016/j.jacc.2014.07.957
[3]	DI MINNO A, SPADARELLA G, PRISCO D, et al. Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: clinical translation and areas of research[J]. Blood Rev, 2015, 29(5): 335-343. doi: 10.1016/j.blre.2015.03.004
[4]	CHANG H Y, ZHOU M, TANG W, et al. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study[J]. BMJ, 2015, 350: h1585. doi: 10.1136/bmj.h1585
[5]	ABRAHAM N S, SINGH S, ALEXANDER G C, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study[J]. BMJ, 2015, 350: h1857. doi: 10.1136/bmj.h1857
[6]	YANG K T, SUN W C, TSAI T J, et al. The risk of gastrointestinal bleeding between non-vitamin K antagonist oral anticoagulants and vitamin K antagonists in the Asian atrial fibrillation patients: a meta-analysis[J]. Int J Environ Res Public Health, 2020, 18(1): E137. doi: 10.3390/ijerph18010137
[7]	王锦萍, 崔毅, 王锦辉, 等. 上消化道出血15年临床流行病学变化趋势[J]. 中华胃肠外科杂志, 2017, 20(4): 425-431. doi: 10.3760/cma.j.issn.1671-0274.2017.04.012
[8]	庞秀峰, 石斌, 王缓缓, 等. 老年急性上消化道出血合并感染的临床特点与预后分析[J]. 实用临床医药杂志, 2020, 24(22): 32-35, 40. doi: 10.7619/jcmp.202022009
[9]	王海燕, 顿晓熠, 柏愚, 等. 中国上消化道出血的临床流行病学分析[J]. 中华消化内镜杂志, 2013, 30(2): 83-86. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS202228044.htm
[10]	雷振民, 汪希. 冠心病患者双联抗血小板治疗中上消化道出血影响因素分析[J]. 实用临床医药杂志, 2020, 24(14): 112-114. doi: 10.7619/jcmp.202014031
[11]	抗血小板药物消化道损伤的预防和治疗中国专家共识组. 抗血小板药物消化道损伤的预防和治疗中国专家共识(2012更新版)[J]. 中华内科杂志, 2013, 52(3): 264-270. doi: 10.3760/cma.j.issn.0578-1426.2013.03.027
[12]	崔凝, 罗和生. 抗凝或抗血小板药物致消化系统损伤的相关因素分析[J]. 中华医学杂志, 2014, 94(20): 1553-1558. doi: 10.3760/cma.j.issn.0376-2491.2014.20.009
[13]	KOSKINAS K C, RÄBER L, ZANCHIN T, et al. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions[J]. Circ Cardiovasc Interv, 2015, 8(5): e002053. doi: 10.1161/CIRCINTERVENTIONS.114.002053
[14]	抗栓治疗消化道损伤防治专家组. 抗栓治疗消化道损伤防治中国专家建议(2016·北京)[J]. 中华内科杂志, 2016, 55(7): 564-567. doi: 10.3760/cma.j.issn.0578-1426.2016.07.020
[15]	邓园园, 黄应文, 熊红, 等. 非甾体类抗炎药相关性上消化道出血的危险因素及凝血相关指标分析[J]. 实用临床医药杂志, 2022, 26(7): 13-17, 21. doi: 10.7619/jcmp.20214025
[16]	林三仁. 消化内科学高级教程[M]. 北京: 人民军医出版社, 2009: 199-202.
[17]	CLEMENS A, STRACK A, NOACK H, et al. Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions[J]. Ann Med, 2014, 46(8): 672-678.

Cited By

Cited by

Periodical cited type(6)

1.	杨虹，季红珍，黄萍，陈善美. 腹部联合阴道超声用于生育“二孩”或“三孩”瘢痕子宫孕妇孕早期胎盘植入诊断的价值. 生殖医学杂志. 2024(06): 813-816 .
2.	谢贤海，郑宗杰. 经阴道彩色多普勒超声心动图诊断宫颈部胎盘植入的效果. 医疗装备. 2023(05): 66-69 .
3.	时明芳，常书娟，张聪祎. 超声评分法联合血浆人胎盘催乳素水平检测对前置胎盘合并胎盘植入的诊断价值. 中国医药导报. 2023(09): 97-100 .
4.	高莉，张玉琴，薛祖兵，王小漫，徐庆. 产前不同超声特征对瘢痕子宫胎盘植入的评价分析. 生殖医学杂志. 2023(05): 759-762 .
5.	孙雪，高霞，刘博，周春花，李云鹏. 孕妇胎盘内部血流参数与妊高症关系研究. 西部医学. 2023(05): 765-769 .
6.	张敬丽，谷小乐，元丽芝. 二维超声及彩色多普勒超声诊断孕晚期胎盘植入的价值. 临床医学. 2022(10): 81-83 .

Other cited types(0)

Get Citation

PDF

XML

Article views (184) PDF downloads (12) Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Clinical characteristics and etiology analysis of nonvariceal upper gastrointestinal bleeding in the treatment of different antithrombotic drugs

Abstract

References

Cited by

Periodical cited type(6)

Other cited types(0)

Catalog

Export File

Citation

Format

Content